33 results
8-K
ONCR
Oncorus, Inc.
5 Aug 22
Regulation FD Disclosure
7:10am
(a) of the Exchange Act. ☐
Item 7.01 Regulation FD Disclosure.
Oncorus, Inc. (the “Company”) from time to time presents and/or distributes to the investment community
424B5
ONCR
Oncorus, Inc.
19 Nov 21
Prospectus supplement for primary offering
4:41pm
treatment centers, third-party payors and others in the medical community necessary for commercial success. The revenues that we generate from
S-3
k1k2x9y0tm1t
3 Nov 21
Shelf registration
5:00pm
10-K
edn5py2t3
10 Mar 21
Annual report
4:12pm
424B4
9vlsl b22t0
12 Feb 21
Prospectus supplement with pricing info
4:23pm
DRS
mwk3fi3r4wang yf0j6
28 Jan 21
Draft registration statement
12:00am
DRS
EX-10.12
99mx298h2ns
28 Jan 21
Draft registration statement
12:00am
8-K
EX-99.1
e1tm 0jf0t
7 Dec 20
Oncorus Appoints Steve Harbin as Chief Operating Officer and Chief of Staff
9:17am
10-Q
phy8z2v0aq
12 Nov 20
Quarterly report
8:01am
424B4
e3me7r
2 Oct 20
Prospectus supplement with pricing info
12:00am